|
|
|
| Esperoct® is used to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. Please see full indication and limitation below. |
|
|
|
| Did you know Esperoct® has a flexibility factor? |
|
|
|
| Did you know Esperoct® has a flexibility factor? |
| See how Esperoct® takes the heat |
| Esperoct® has a flexibility factor that can fit into your active lifestyle. Take it with you on the go, even on hot days. |
|
 |
Esperoct® is the only extended half-life product that can go with you up to 104 °Fa |
|
|
 |
After reconstitution, Esperoct® can be used up to 4 hours at up to 86 °Fb |
|
|
 |
After reconstitution, you can store Esperoct® in the refrigerator for up to 24 hoursb,c |
|
|
 |
Esperoct® is ready in 3 simple steps—infuse in 2 minutesd |
|
|
|
 |
Esperoct® offers portable and flexible storage across all age groups |
|
|
|
|
| bSee Prescribing Information for complete product storage information. Store reconstituted product in vial. |
| cAfter reconstitution, Esperoct® can be stored in the refrigerator between 36 °F to 46 °F for up to 24 hours. |
| dFor full instructions, please see the Instructions for Use provided with the Prescribing Information. |
|
| Selected Important Safety Information |
| Who should not use Esperoct®? |
| |
• |
You should not use Esperoct® if you are allergic to factor VIII or any of the other ingredients of Esperoct® or if you are allergic to hamster proteins |
|
| What is the most important information I need to know about Esperoct®? |
| |
• |
Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center |
|
| |
• |
Call your healthcare provider right away or get emergency treatment right away if you get any signs of an allergic reaction, such as: hives, chest tightness, wheezing, dizziness, difficulty breathing, and/or swelling of the face |
|
| Please click here or scroll below for additional Important Safety Information. |
|
|
Discover bleed protection
with Esperoct® |
|
|
|
|
 |
| Get support in your community |
| Connect with a Rare Blood Community Liaison (RBCL) to get personalized support, find local events, and learn more about Esperoct®. |
|
|
|
|
|
|
| What is Esperoct®? |
| Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] is an injectable medicine to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. Your healthcare provider may give you Esperoct® when you have surgery |
| |
• |
Esperoct® is not used to treat von Willebrand Disease |
|
| Important Safety Information (cont’d) |
| What should I tell my healthcare provider before using Esperoct®? |
| |
• |
Before taking Esperoct®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII |
| |
• |
Your body can make antibodies called “inhibitors” against Esperoct®, which may stop Esperoct® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Esperoct® |
|
| What are the possible side effects of Esperoct®? |
| |
• |
Common side effects of Esperoct® include rash or itching, and swelling, pain, rash or redness at the location of infusion |
|
| Please click here for Prescribing Information. |
| Esperoct® is a prescription medication. |
| You are encouraged to report negative side effects of prescription drugs to the FDA. |
| Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. |
|
|
| PLEASE DO NOT RESPOND TO THIS EMAIL. If you would like to contact us, please click here or call 1‑877‑744‑2579. |
| UNSUBSCRIBE NOTICE |
| If you no longer want to receive communications from Novo Nordisk, click here to unsubscribe. You also may call us at 1-877-744-2579 or send us a letter that includes your full contact information (eg, name, email address, phone) to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536. To better understand how Novo Nordisk values your privacy, see our Privacy Statement. |
|
Esperoct® is a registered trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
© 2024 Novo Nordisk All rights reserved. US24ESP00081 October 2024 |
 |
|
|
|
